Covista (CVSA) Cash & Equivalents (2009 - 2026)

Covista (CVSA) has 18 years of Cash & Equivalents data on file, last reported at $1.9 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $1.9 million, down 13.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 million (down 13.96% YoY), and the FY2025 annual result was $199.6 million, up 10427.48% from the prior year.
• Cash & Equivalents slipped to $1.9 million in Q1 2026 per CVSA's latest filing, from $56.3 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $788.7 million in Q1 2022 and troughed at $964000.0 in Q2 2022.
• A 5-year average of $121.8 million and a median of $4.2 million in 2022 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents slumped 99.88% in 2022, then jumped 10427.48% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $206.3 million in 2022, then plunged by 98.46% to $3.2 million in 2023, then plunged by 54.1% to $1.5 million in 2024, then soared by 3752.22% to $56.3 million in 2025, then slumped by 96.69% to $1.9 million in 2026.
• Business Quant data shows CVSA's Cash & Equivalents at $1.9 million in Q1 2026, $56.3 million in Q4 2025, and $264.7 million in Q3 2025.